Imaging for early stage breast cancer

≥ 50 years old Suitable Group The American Brachytherapy Society consensus statement for APBI (Shah C et al, Brachytherapy 2013) ) Approved in April 2012 Members of ABS with expertise in breast cancer

Age

and in particular breast brachytherapy

Size

≤ 3 cm

Histology

All invasive subtypes and DCIS Systematic review of the literature

41 nonrandomized trials

Estrogen receptor

Positive/Negative 5 randomiz d trials

Surgical margins

Negative

Lymphovascular space invasion

Not present

Negative

Nodal status